Peter H Nissen
Overview
Explore the profile of Peter H Nissen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nissen P, Pedersen O
Semin Thromb Hemost
. 2025 Mar;
PMID: 40074010
Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide, with platelet reactivity playing a central role in its pathogenesis. Recent research has identified microRNAs (miRNAs; miRs)...
2.
Pedersen O, Nissen P, Pasalic L, Hvas A, Kristensen S, Grove E
Res Pract Thromb Haemost
. 2025 Jan;
9(1):102652.
PMID: 39845649
Background: Reduced effect of antiplatelet therapy has been reported in patients with ST-segment elevation myocardial infarction (STEMI). This could partly be explained by an increase of highly reactive immature platelets....
3.
Bhattacharya S, Nissen P
Scand J Clin Lab Invest
. 2024 Aug;
84(6):421-424.
PMID: 39180490
It is common practice in laboratories to store biological samples in ultra-low temperature (ULT) freezers. There is growing interest in raising the temperature of ULT freezers in order to save...
4.
Pedersen O, Hvas A, Nissen P, Pasalic L, Kristensen S, Grove E
Thromb Res
. 2024 Apr;
237:100-107.
PMID: 38579511
Background: Reduced effect of antiplatelet therapy has been reported in patients with ST-segment elevation myocardial infarction (STEMI). Multiple factors may concur to explain this, including increased amount of highly reactive...
5.
Nissen P, Mikkelsen T, Hojskov C, Hojbjerg J
Scand J Clin Lab Invest
. 2024 Feb;
84(1):68-70.
PMID: 38300114
No abstract available.
6.
Pedersen O, Hvas A, Pasalic L, Kristensen S, Grove E, Nissen P
Thromb Haemost
. 2023 Oct;
124(3):192-202.
PMID: 37846463
Background: Reduced effect of antiplatelet therapy has been reported in patients with ST-segment elevation myocardial infarction (STEMI). MicroRNAs (miRs) may influence platelet function and maturity, and subsequently the effect of...
7.
Kjeldsen P, Parbo P, Hansen K, Aanerud J, Ismail R, Nissen P, et al.
Aging Brain
. 2023 Mar;
2:100048.
PMID: 36908895
Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer's disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of...
8.
Winther-Larsen A, Madsen A, Nissen P, Hoffmann-Lucke E, Greibe E
Clin Chem Lab Med
. 2023 Mar;
61(8):1490-1496.
PMID: 36856054
Objectives: Plasma uracil is a new biomarker to assess the activity of dihydropyrimidine dehydrogenase before cancer treatment with fluoropyrimidine drugs. Knowledge on the biological variation of plasma uracil is important...
9.
Nissen P, Narvestad-Bottger H, Kristensen H, Winther-Larsen A
EJHaem
. 2023 Feb;
4(1):18-25.
PMID: 36819175
When screening for α-thalassemia in children, adult cut-offs for mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) are generally applied to guide genetic evaluation. However, the normal ranges for...
10.
Pedersen O, Pasalic L, Grove E, Kristensen S, Hvas A, Nissen P
Methods Protoc
. 2023 Jan;
6(1).
PMID: 36648957
Newly produced immature platelets are larger, contain higher amounts of residual RNA, and are more reactive than mature platelets. Flow cytometry using the SYTO-13 dye is a method for the...